Literature DB >> 15986445

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.

Carey A Cullinane1, Jan Lubinski, Susan L Neuhausen, Parviz Ghadirian, Henry T Lynch, Claudine Isaacs, Barbara Weber, Pal Moller, Kenneth Offit, Charmaine Kim-Sing, Eitan Friedman, Susan Randall, Barbara Pasini, Peter Ainsworth, Ruth Gershoni-Baruch, William D Foulkes, Jan Klijn, Nadine Tung, Gad Rennert, Olufunmilayo Olopade, Fergus Couch, Teresa Wagner, Hakan Olsson, Ping Sun, Jeffrey N Weitzel, Steven A Narod.   

Abstract

Early age at first birth and multiparity have been associated with a decrease in the risk of breast cancer in women in the general population. We examined whether this relationship is also present in women at high risk of breast cancer due to the presence of a mutation in either of the 2 breast cancer susceptibility genes, BRCA1 or BRCA2. We performed a matched case-control study of 1,260 pairs of women with known BRCA1 or BRCA2 mutations, recruited from North America, Europe and Israel. Women who had been diagnosed with breast cancer were matched with unaffected control subjects for year of birth, country of residence, and mutation (BRCA1 or BRCA2). Study subjects completed a questionnaire detailing their reproductive histories. Odds ratios (ORs) and 95% confidence intervals (CIs) were derived by conditional logistic regression. Among BRCA1 carriers, parity per se was not associated with the risk of breast cancer (OR for parous vs. nulliparous = 0.94; 95% CI = 0.75-1.19; p = 0.62). However, women with a BRCA1 mutation and 4 or more children had a 38% decrease in breast cancer risk compared to nulliparous women (OR = 0.62; 95% CI = 0.41-0.94). In contrast, among BRCA2 carriers, increasing parity was associated with an increased risk of breast cancer; women with 2 or more children were at approximately 1.5 times the risk of breast cancer as nulliparous women (OR = 1.53; 95% CI = 1.01-2.32; p = 0.05). Among women with BRCA2 mutations and who were younger than age 50, the (adjusted) risk of breast cancer increased by 17% with each additional birth (OR = 1.17; 95% CI = 1.01-1.36; p = 0.03). There was no significant increase in the risk of breast cancer among BRCA2 carriers older than 50 (OR for each additional birth = 0.97; 95% CI = 0.58-1.53; p = 0.92). In the 2-year period following a birth, the risk of breast cancer in a BRCA2 carrier was increased by 70% compared to nulliparous controls (OR = 1.70; 95% CI = 0.97-3.0). There was a much smaller increase in breast cancer risk among BRCA2 carriers whose last birth was 5 or more years in the past (OR = 1.24; 95% CI = 0.79-1.95). A modest reduction in risk of breast cancer was observed among BRCA1 carriers with 4 or more births. Among BRCA2 carriers, increasing parity was associated with a significant increase in the risk of breast cancer before age 50 and this increase was greatest in the 2-year period following a pregnancy. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Year:  2005        PMID: 15986445     DOI: 10.1002/ijc.21273

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  46 in total

1.  Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

Authors:  Nadine Andrieu; David E Goldgar; Douglas F Easton; Matti Rookus; Richard Brohet; Antonis C Antoniou; Susan Peock; Gareth Evans; Diana Eccles; Fiona Douglas; Catherine Noguès; Marion Gauthier-Villars; Agnès Chompret; Flora E Van Leeuwen; Irma Kluijt; Javier Benitez; Brita Arver; Edith Olah; Jenny Chang-Claude
Journal:  J Natl Cancer Inst       Date:  2006-04-19       Impact factor: 13.506

2.  Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.

Authors:  M H Herynk; M T Lewis; T A Hopp; D Medina; A Corona-Rodriguez; Y Cui; A R Beyer; S A W Fuqua
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

3.  Pregnancy after Breast Cancer: Myths and Facts.

Authors:  Olivia Pagani; Hatem Azim
Journal:  Breast Care (Basel)       Date:  2012-06-27       Impact factor: 2.860

Review 4.  Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.

Authors:  Tara M Friebel; Susan M Domchek; Timothy R Rebbeck
Journal:  J Natl Cancer Inst       Date:  2014-06       Impact factor: 13.506

5.  Reducing the Risk of Gynecologic Cancer in Hereditary Breast Ovarian Cancer Syndrome Mutation Carriers: Moral Dilemmas and the Principle of Double Effect.

Authors:  Murray Joseph Casey; Todd A Salzman
Journal:  Linacre Q       Date:  2018-07-20

6.  Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.

Authors:  Sibgat Choudhury; Vanessa Almendro; Vanessa F Merino; Zhenhua Wu; Reo Maruyama; Ying Su; Filipe C Martins; Mary Jo Fackler; Marina Bessarabova; Adam Kowalczyk; Thomas Conway; Bryan Beresford-Smith; Geoff Macintyre; Yu-Kang Cheng; Zoila Lopez-Bujanda; Antony Kaspi; Rong Hu; Judith Robens; Tatiana Nikolskaya; Vilde D Haakensen; Stuart J Schnitt; Pedram Argani; Gabrielle Ethington; Laura Panos; Michael Grant; Jason Clark; William Herlihy; S Joyce Lin; Grace Chew; Erik W Thompson; April Greene-Colozzi; Andrea L Richardson; Gedge D Rosson; Malcolm Pike; Judy E Garber; Yuri Nikolsky; Joanne L Blum; Alfred Au; E Shelley Hwang; Rulla M Tamimi; Franziska Michor; Izhak Haviv; X Shirley Liu; Saraswati Sukumar; Kornelia Polyak
Journal:  Cell Stem Cell       Date:  2013-06-13       Impact factor: 24.633

7.  Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer.

Authors:  Kenny A Rodriguez-Wallberg; Kutluk Oktay
Journal:  Oncologist       Date:  2012-09-24

8.  Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.

Authors:  Ashley D Staton; Allison W Kurian; Kristin Cobb; Meredith A Mills; James M Ford
Journal:  Fam Cancer       Date:  2007-11-17       Impact factor: 2.375

Review 9.  Pregnancy and breast cancer: when they collide.

Authors:  Traci R Lyons; Pepper J Schedin; Virginia F Borges
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-21       Impact factor: 2.673

10.  Selected aspects of genetic counselling for BRCA1 mutation carriers.

Authors:  Jacek Gronwald
Journal:  Hered Cancer Clin Pract       Date:  2007-03-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.